Online inquiry

IVTScrip™ mRNA-Human ASL, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28716MR)

This product GTTS-WK28716MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASL protein. This product can be used in Natural killer cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_000048.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 435
UniProt ID P04424
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASL, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28716MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK15415MR IVTScrip™ mRNA-Human ALG2, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ALG2
GTTS-WK23365MR IVTScrip™ mRNA-Human ATIC, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATIC
GTTS-WK10511MR IVTScrip™ mRNA-Human AADAC, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AADAC
GTTS-WK23912MR IVTScrip™ mRNA-Human ASH1L, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASH1L
GTTS-WK16901MR IVTScrip™ mRNA-Human ALDH3B1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ALDH3B1
GTTS-WK14313MR IVTScrip™ mRNA-Human ADARB1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADARB1
GTTS-WK1701MR IVTScrip™ mRNA-Human ALDH, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALDH
GTTS-WK12904MR IVTScrip™ mRNA-Human 3A7, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA 3A7
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →